Phase I/II clinical trial of human embryonic stem cell (hESC)-derived retinal pigmented epithelium (RPE) transplantation in Stargardt disease (STGD): One-year results

被引:0
|
作者
Mehat, Manjit Singh [1 ,2 ]
机构
[1] UCL Inst Ophthalmol, London, England
[2] NIHR Moorfields Biomed Res Ctr, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页数:2
相关论文
共 43 条
  • [31] cGMP Compliant Production for Human Embryonic Stem Cell Derived Retinal Pigment Epithelial Cells on a Synthetic Substrate for the Treatment of Non-Neovascular Age-Related Macular Degeneration for Phase I Clinical Study
    Lopez, P. M.
    Aguilar, T.
    Wu, Rl
    Krishnan, A.
    Kong, D.
    Patel, J.
    Javier, H.
    Dang, W.
    Wong, D.
    Zhu, D.
    Dodd, J.
    Shad, Y.
    Humayun, M.
    Hinton, D. R.
    Clegg, D. O.
    Johnson, L. V.
    Lin, C. M.
    Hsu, D.
    Couture, L.
    MOLECULAR THERAPY, 2016, 24 : S176 - S176
  • [32] Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial
    Lang, Peter J.
    Schlegel, Paul G.
    Meisel, Roland
    Schulz, Ansgar S.
    Greil, Johann
    Bader, Peter
    Karitzky, Sandra
    Holtkamp, Silke
    Siewert, Christiane
    Pflitsch, Stefanie
    Schumm, Michael
    Eyrich, Matthias K.
    Wiesneth, Markus
    Bonig, Halvard
    Handgretinger, Rupert
    BLOOD, 2017, 130
  • [33] Results of a Two-Arm Phase II Clinical Trial Using Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease in Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem-Cell Transplantation
    Gaballa, Sameh
    Ge, Isabell
    El Fakih, Riad O.
    Brammer, Jonathan E.
    Wang, Sa A.
    Lee, Dean A.
    Petropoulos, Demetrios
    Cao, Kai
    Rondon, Gabriela
    Chen, Julianne
    Hammerstrom, Aimee E.
    Al-Atrash, Gheath
    Korbling, Martin
    Oran, Betul
    Kebriaei, Partow
    Ahmed, Sairah
    Shah, Nina
    Rezvani, Katayoun
    Marin, David
    Bashir, Qaiser
    Alousi, Amin M.
    Nieto, Yago
    Qazilbash, Muzaffar H.
    Hosing, Chitra M.
    Popat, Uday R.
    Shpall, Elizabeth J.
    Khouri, Issa F.
    Champlin, Richard E.
    Ciurea, Stefan O.
    BLOOD, 2015, 126 (23)
  • [34] First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning
    Bethge, Wolfgang
    Mielke, Stephan
    Niederwieser, Dietger
    Meisel, Roland
    Bunjes, Donald W.
    Brecht, Arne
    Kuball, Jurgen
    Karitzky, Sandra
    Holtkamp, Silke
    Siewert, Christiane
    Pflitsch, Stefanie
    Schumm, Michael
    Eyrich, Matthias K.
    Vucinic, Vladan
    Wiesneth, Markus
    Westinga, Kasper
    Handgretinger, Rupert
    BLOOD, 2017, 130
  • [35] TCR-Alpha/ Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/ II Clinical Trial
    Lang, Peter J.
    Schlegel, Paul G.
    Meisel, Roland
    Schulz, Ansgar S.
    Greil, Johann
    Bader, Peter
    Karitzky, Sandra
    Holtkamp, Silke
    Siewert, Christiane
    Schumm, Michael
    Eyrich, Matthias K.
    Wiesneth, Markus
    Bonig, Halvard
    Handgretinger, Rupert
    BLOOD, 2016, 128 (22)
  • [36] Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation
    Jamy, Omer
    Innis-Shelton, Raquel
    Bal, Susan
    Paluri, Ravi
    Salzman, Donna
    Di Stasi, Antonio
    Costa, Luciano
    Meredith, Ruby
    Lamb, Lawrence
    Minagawa, Kentaro
    Mineishi, Shin
    Saad, Ayman
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : E396 - E398
  • [37] Long-term Safety of a Single Infusion of Human Umbilical Cord Blood-derived Mesenchymal Stem Cell Therapy in Rheumatoid Arthritis: The 5-year Follow-up of the Phase I Clinical Trial
    Kim, Min Jung
    Park, Eun Hye
    Shin, Kichul
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3566 - 3567
  • [38] Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial
    Baolin, Tang
    Lee, Jongbok
    Cheng, Siqi
    Yao, Wen
    Wang, Dongyao
    Tu, Meijuan
    Xiang, Zhiqiang
    Geng, Liangquan
    Wang, Mingxia
    Qiang, Ping
    Teng, Pingping
    Sun, Guangyu
    Pan, Tianzhong
    Liu, Huilan
    Yang, Liming
    Sun, Zimin
    Zhang, Li
    Zhu, Xiaoyu
    BLOOD, 2020, 136
  • [39] Results of a Phase II Clinical Trial of Tocilizumab, Tacrolimus and Methotrexate (Toc/Tac/MTX) for the Prevention of Acute Graft Versus Host Disease (GVHD) and Matched Case Control Comparison to Tac/MTX after Allogeneic Stem Cell Transplantation
    Drobyski, William
    Szabo, Aniko
    Hari, Parameswaran
    Hamadani, Mehdi
    Herbert, Kyle
    Keever-Taylor, Carolyn
    D'Souza, Anita
    Eapen, Mary
    Fenske, Timothy S.
    Horowitz, Mary M.
    Rizzo, J. Douglas
    Saber, Wael
    Shah, Nirav
    Shaw, Bronwen E.
    Yim, Sharon
    Pasquini, Marcelo C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S89 - S89
  • [40] Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial
    Yamahara, Kenichi
    Hamada, Akiko
    Soma, Toshihiro
    Okamoto, Rika
    Okada, Masaya
    Yoshihara, Satoshi
    Yoshihara, Kyoko
    Ikegame, Kazuhiro
    Tamaki, Hiroya
    Kaida, Katsuji
    Inoue, Takayuki
    Ohsugi, Yuko
    Nishikawa, Hiroki
    Hayashi, Hiroshi
    Ito, Yoichi M.
    Iijima, Hiroaki
    Ohnishi, Shunsuke
    Hashimoto, Daigo
    Isoe, Toshiyuki
    Teshima, Takanori
    Ogawa, Hiroyasu
    Sato, Norihiro
    Fujimori, Yoshihiro
    BMJ OPEN, 2019, 9 (07):